Characterization of long-term users of nicotine replacement therapy: Evidence from a national survey

Nicotine and Tobacco Research

Volumn 16, Issue 8, 2014, Pages 1050-1055

  Silla, Kabay ^a   Beard, Emma ^a   Shahab, Lion ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTITUDE; DEMOGRAPHY; FEMALE; HARM REDUCTION; HEALTH SURVEY; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; OCCUPATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOKING; SMOKING CESSATION; SUBSTITUTION THERAPY; TOBACCO USE; MIDDLE AGED; MOTIVATION; PROCEDURES; PSYCHOLOGY; TOBACCO USE DISORDER; UNITED KINGDOM;

NICOTINE; NICOTINE GUM; NICOTINIC AGENT;

ADULT; ENGLAND; FEMALE; HARM REDUCTION; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NICOTINE; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84904337636     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu019     Document Type: Article

References (27)

1. Agboola, S., McNeill, A., Coleman, T., & Bee, J. L. (2010). A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction (Abingdon, England), 105, 1362-1380. doi:10.1111/j.1360-0443.2010.02996.x.
2. Bansal, M. A., Cummings, K. M., Hyland, A., & Giovino, G. A. (2004). Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them? Nicotine & Tobacco Research, 6(Suppl. 3), S303-S310. doi:10.1080/14622200412331320707.
3. Beard, E., Aveyard, P., Brown, J., & West, R. (2012). Assessing the association between the use of NRT for smoking reduction and attempts to quit smoking using propensity score matching. Drug and Alcohol Dependence, 126, 354-361. doi:10.1016/j.drugalcdep.2012.05.039.x.
4. Beard, E., Aveyard, P., Michie, S., McNeill, A., & West, R. (2013). Does use of nicotine replacement therapy while continuing to smoke undermine cessation?: A systematic review. Volume of Smoking Cessation, 8, 45-56. doi:10.1017/jsc.2012.21.
5. Beard, E., Bruguera, C., Brown, J., McNeill, A., & West, R. (2013). Was the expansion of the marketing license for nicotine replacement therapy in the United Kingdom to include smoking reduction associated with changes in use and incidence of quit attempts? Nicotine & Tobacco Research, 15, 1777-1781. doi:10.1093/ntr/ntt044.x.
6. Beard, E., McNeill, A., Aveyard, P., Fidler, J., Michie, S., & West, R. (2011). Association between use of nicotine replacement therapy for harm reduction and smoking cessation: A prospective study of English smokers. Tobacco Control, 22, 118-122. doi:10.1136/tobaccocontrol-2011-050007.x.
7. Beard, E., Vangeli, E., Michie, S., & West, R. (2012). The use of nicotine replacement therapy for smoking reduction and temporary abstinence: An interview study. Nicotine & Tobacco Research, 14, 849-856. doi:10.1093/ntr/ntr297.x.
8. Benowitz, N. L., Zevin, S., & Jacob, P. (1998). Suppression of nicotine intake during ad libitum cigarette smoking by highdose transdermal nicotine. Journal of Pharmacology and Experimental Therapeutics, 287, 958-962. Retrieved from http://jpet.aspetjournals.org/.
9. Botello-Harbaum, M., Schroeder, J. R., Collins, C. C., & Moolchan, E. T. (2010). Nicotine replacement therapy use among adolescent smokers seeking cessation treatment. Ethnicity & Disease, 20, 180-184. Retrieved from www.ishib.org/ED/.
10. Carpenter, M. J., Ford, M. E., Cartmell, K., & Alberg, A. J. (2011). Misperceptions of nicotine replacement therapy within racially and ethnically diverse smokers. Journal of the National Medical Association, 103, 885-894. Retrieved from www.ncbi.nlm.nih.gov/pmc/articles/PMC3372924/.
11. Courtenay, W. H. (2000). Constructions of masculinity and their influence on men's well-being: A theory of gender and health. Social Science & Medicine, 50, 1385-1401. doi:10.1016/S0277-9536(99)00390-1.x.
12. Davis, J. (2007). Nicotine replacement therapy: VAT reduction and sales of NRT: A report commissioned for ASH. Retrieved October 15, 2013, from www.ash.org.uk/files/documents/ASH_696.pdf.
13. Emmons, K. M., Goldstein, M. G., Roberts, M., Cargill, B., Sherman, C. B., Millman, R., Abrams, D. B. (2000). The use of nicotine replacement therapy during hospitalization. Annals of Behavioural Medicine, 22, 325-329. doi:10.1007/BF02895669.
14. Etter, J. F., & Perneger, T. V. (2001). Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clinical Pharmacology and Therapeutics, 69, 175-183. doi:10.1067/mcp.2001.113722.x.
15. Fagerström, K.-O., Schneider, N. G., & Lunell, E. (1993). Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology, 111, 271-277. doi:10.1007/BF02244941.
16. Fidler, J. A., Shahab, L., West, O., Jarvis, M. J., McEwen, A., Stapleton, J. A., West, R. (2011). 'The smoking toolkit study': A national study of smoking and smoking cessation in England. BMC Public Health, 11, 479. doi:10.1186/1471-2458-11-479.x.
17. Hammond, D., Reid, L., Driezen, P., Cummings, M., Borland, R., Fong, G. T., Hughes, J. R. (2008). Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: Findings from the ITC Country Survey. Addiction, 103, 1696-1703. doi:10.1111/j.1360-0443.2008.02320.x.
18. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., Rickert, W., & Robinson, J. (1989). Measuring the heaviness of smoking using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction, 84, 791-800. doi:10.1111/j.1360-0443.1989.tb03059.x.
19. Horne, R., & Weinman, J. (1999). Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47, 555-567. doi:10.1016/S0022-3999(99)00057-4.
20. Kotz, D., Fidler, J., & West, R. (2009). Factors associated with the use of aids to cessation in English smokers. Addiction (Abingdon, England), 104, 1403-1410. doi:10.1111/j.1360-0443.2009.02639.x.
21. Medicines and Healthcare Products Regulatory Agency. (2009). MHRA public assessment report: The use of nicotine replacement therapy to reduce harm in smokers. London, UK: Author.
22. Moore, D., Aveyard, P., Connock, M., Wang, D., Fry-Smith, A., & Barton, P. (2009). Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-analysis. BMJ, 338, b1024. doi:10.1136/bmj.b1024.x.
23. National Institute of Health and Care Excellence. (2013). Tobacco-Harm reduction. Retrieved July 15, 2013, from www.webcitation.org/6I8H2UsRX.
24. Shahab, L., Hammond, D., Borland, R., Cummings, K. M., West, R., & McNeill, A. (2009). The impact of relaxing NRT licensing laws in the UK: Findings from the International Tobacco Control Four Country Survey. Addiction, 104, 1420-1427. Retrieved from http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1360-0443.
25. Wang, D., Connock, M., Barton, P., Fry-Smith, A., Aveyard, P., & Moore, D. (2008). 'Cut down to quit' with nicotine replacement therapies in smoking cessation: A systematic review of effectiveness and economic analysis. Health Technology Assessment, 12, 1-135. Retrieved from www.hta.ac.uk/.
26. West, R. (2006). Theory of addiction. Oxford, UK: Blackwell.
27. World Health Organization. (2012). WHO global report: Mortality attributable to tobacco. Retrieved July 11, 2012, from http://whqlibdoc.who.int/publications/2012/9789241564434_eng.pdf.